Purposeful innovation. Empowered care.
Philips at EuroPCR 2023 16-19 May, Palais des Congrès, Paris.
We look forward to connecting with you online or at our Philips booth.
To empower better heart care, Philips uniquely innovates and integrates imaging, devices, software, informatics and services
Join our symposium - 60 minutes
17 May | 12:15 -13:15 CEST | Room 252B
Ultra-low contrast PCI - an indispensable toolset in complex coronary interventions and higher-risk patients
Moderator : Roberto Garbo
Anchorperson: Dariusz Dudek
Speakers: Nieves Gonzalo, Javier Escaned, Ajay J Kirtane, Abdul Mozid
Join our case in point - 45 minutes
16 May | 13:45-14:30 CEST | Studio A
Physiologic guidance and optimisation in multivessel disease
Moderator : Rasha Al-Lamee
Anchorperson: Nieves Gonzalo
Speakers: Matthias Götberg, Javier Escaned, Eric Van Belle
Philips at EuroPCR 2023 16-19 May, Palais des Congrès, Paris.
Late-breaking clinical data – join the sessions at EuroPCR
Tuesday 16 May – 12:00-13:30 – Room Maillot Dynamic coronary roadmap for contrast reduction trial, Javier Escaned Thursday 18 May – 15:15-16:45 – Room Maillot
iFR vs. FFR-guided revascularisation decision-making in left main disease,
Takayuki Warisawa
DEFINE-FLAIR: five-year follow-up, Javier Escaned
Training village
Our solutions support interventionalists in minimizing the contrast-load for the patient and physicians, and in performing interventional procedures with clarity and confidence, improving cardiac care experiences for staff and patients. Join our training village at EuroPCR and learn more.
Simulation learning room
New study reveals six technology factors to address CAD care challenges
In-depth research identified a number of critical factors that could successfully address challenges in the care pathway.
Discover our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Product availability is subject to country regulatory clearance. Please contact your local sales representative to check the availability in your country.
Ultra-low contrast PCI
Most cardiac patients fall under high-risk category for acute kidney injury (AKI) 1
Continuous monitoring
The IntelliVue X3 portable monitor stays connected to the patient for consistent physiological monitoring and timely detection of potential adverse events during every stage of their journey.
Sign up to receive news and updates on our new innovations in cardiology that deliver clinical confidence and efficiency in the diagnosis and treatment in CAD and SHD.
Enter our cardiology virtual space
Explore all the latest Philips cardiology innovations including our informatics solutions which bring meaningful data together across the cardiovascular care continuum.
Clinical solutions
iFR Co-registration
IVUS guidance
Coronary diagnostic for Complex PCI
IntelliSpace Cardiovascular
Our PR Contacts
Joost Maltha Joost.maltha@philips.com Philips Global Press Office Tel: +31 6 10 55 8116
References:
1 Mehran R, Aymong ED, Nikolsky E, et al. A simple risk score for prediction of contrast induced nephropathy after percutaneous coronary intervention: development and initial validation. J Am Coll Cardiol. 2004; 44(7): 1393-1399. doi:10.1016/j.jacc.2004.06.068.
